Reaction of sodium azide with manganese(II) and pyridine derivatives such as 2-bzpy, 3-bzpy, and 3,5lut (2-benzoylpyridine, 3-benzoylpyridine, and 3,5-dimethylpyridine, respectively) led to the one-dimensional systems cis -[Mn(2-bzpy)(N 3 ) 2 ] n ( 1 ), trans -[Mn(3-Bzpy) 2 (N 3 ) 2 ] n ( 2 ), and cis- [Mn(3,5lut) 2 (N 3 ) 2 ] n ( 3 ). Compound 1 crystallizes in the P 2 1 / n group: a = 14.413(4) Å, b = 16.157(4) Å, c = 18.478(5) Å, and Z = 12. Compound 2 crystallizes in the C 2/ c group: a = 14.179(5) Å, b = 9.698(4) Å, c = 34.351(12) Å, and Z = 8. Compound 3 crystallizes in the P 2 1 / n group: a = 13.552(6) Å, b = 7.730(3) Å, c = 16.554(6) Å, and Z = 4. Structural determination shows a chain with double μ 1,1 azido bridges for 1, an alternating system with double μ 1,1 and μ 1,3 azido bridges for 2, and finally a chain with double μ 1,3 azido bridges for 3 . Susceptibility data show ferromagnetic coupling for 1, antiferromagnetic coupling for 3, and alternating ferro−antiferromagnetic interactions for 2 . EPR data measured on powdered samples and single crystals show the ideal Heisenberg narrowing angular dependence for the three kinds of coupled systems and an increasing dipolar broadening mechanism in the order 3 < 2 < 1 according to the decreasing Mn···Mn intrachain distances.
No takes yet. Share an insight, caveat, or question.
Abu-Youssef et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: